mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |